Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Ticker SymbolSTXS
Company nameStereotaxis Inc
IPO dateAug 12, 2004
CEOMr. David Leo Fischel
Number of employees139
Security typeOrdinary Share
Fiscal year-endAug 12
Address710 N Tucker Blvd
CityST. LOUIS
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code63101
Phone13146786100
Websitehttps://www.stereotaxis.com/
Ticker SymbolSTXS
IPO dateAug 12, 2004
CEOMr. David Leo Fischel
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data